deltatrials
Unknown PHASE1 NCT00004307

Study of Treatment and Metabolism in Patients With Urea Cycle Disorders

Therapeutic and Metabolic Studies of Urea Cycle Disorders: Part A: Nitrogen Flux and Ureagenesis; Part B (Closed): Phase I Adenovirus Vector-Mediated Gene Therapy for Ornithine Transcarbamylase Deficiency

Sponsor: Baylor College of Medicine

Conditions Amino Acid Metabolism, Inborn Errors
Interventions Ornithine transcarbamylase vector Protein and calorie controlled diet
Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Dec 31, 1999

Listed as NCT00004307, this PHASE1 trial focuses on Amino Acid Metabolism, Inborn Errors and remains ongoing. Sponsored by Baylor College of Medicine, it has been updated 5 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1

    First recorded

Dec 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baylor College of Medicine
  • National Center for Research Resources (NCRR)
Data source: National Center for Research Resources (NCRR)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Houston, United States